Feasibility of Chemotherapy De-escalation in Early-Stage HER2 Positive Breast Cancer
Status:
Not yet recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this research study is to find out if de-escalation of chemotherapy
before surgery followed by a selective escalation of adjuvant targeted therapies are
efficacious and tolerable in early-stage HER2 positive breast cancer.